about
Cumulative exposure to lead and cognition in persons with Parkinson's diseaseRisk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.Parkinson's disease: no milk today?Spinal surgery in patients with Parkinson's disease: unsatisfactory results, failure and disappointment.Markov Chain Ontology Analysis (MCOA).Bone mineral density (BMD) in male patients with Parkinson's disease.Bone health in Parkinson's disease: a systematic review and meta-analysisProposed Motor Scoring System in a Porcine Model of Parkinson's Disease induced by Chronic Subcutaneous Injection of MPTP.Association of cumulative lead exposure with Parkinson's disease.Idiopathic Parkinson's disease, osteoporosis, and hip fractures: a case report.Osteoporosis and Parkinson's disease.Role of vitamin d in Parkinson's disease.A Selective Corrective Exercise to Decrease Falling and Improve Functional Balance in Idiopathic Parkinson's DiseasePathophysiological Concepts and Treatment of Camptocormia.Bone mass and vitamin D levels in Parkinson's disease: is there any difference between genders?Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signalingHow might physical activity benefit patients with Parkinson disease?Musculoskeletal problems in Parkinson's disease.Parkinson disease and exercise.Occurrence, management and outcomes of hip fractures in patients with Parkinson's disease.[Lumbar back pain in patients with Parkinson's disease].Comorbid Parkinson's disease, falls and fractures in the 2010 National Emergency Department Sample.[Spinal deformity in Parkinson's disease: a treatment proposal].Bone mineral density and vitamin D status in Parkinson's disease patients.Parkinson?s Disease and Osteoporosis.A novel approach for correction of crosstalk effects in pathway analysis and its application in osteoporosis research.Effect of Vitamin D in HN9.10e Embryonic Hippocampal Cells and in Hippocampus from MPTP-Induced Parkinson's Disease Mouse Model.
P2860
Q28394876-81FE498C-6B29-4F4F-872E-64E423471890Q30248491-068F9F1C-30AD-41A1-80BE-561BBEF6AD61Q30300817-418A8CC4-4320-4B42-BF45-7E84EFBD64BCQ34139664-301E954E-ECB9-4953-A77E-86D5FF4753A2Q34147702-D1A56E69-817F-428F-8A8E-427E252B1523Q34149066-7B028844-B376-451C-8AB7-1619DC630E4FQ34235944-AC5CC895-B5B5-4D42-9672-E9DEE2847465Q34237651-119FEDBB-4FE9-4729-9065-7F604C550116Q34241599-62E4CEF1-3698-4472-9B8F-0CF1D373EFC3Q34282891-C74F3E1B-4AFE-4E55-AFB3-0B9D62E6BA12Q34569971-2F84B857-5B36-4A54-A6EA-670D87E94597Q35755681-911E7170-6C0F-4C4A-B82D-945560AEB11EQ35949729-CA69C5F8-CD87-4F8B-A6BC-A2F75B27E43BQ36907522-03071E33-328F-4BDC-8CAD-0CC6FB0AFCA3Q37225144-4E8FD242-8A33-4C12-A719-DB7FFBE243DFQ37232448-CC1C438E-2C6E-47E5-8318-7282A777A6A3Q37401906-E1A36B88-B3A4-44B4-8FDA-AF9781283704Q37595673-8A8DE293-3994-4F79-860F-2A486778CCDEQ37900480-13907587-A6E4-4B2F-A1E1-8F52E49B6AC7Q38082685-F5CBA1EF-935C-4A37-9F21-09DB01AD0E7BQ38110523-4BDD8480-E62B-43AB-AAF5-5F134DDBB105Q38541233-8BE75EF5-D0C1-42CC-A448-6F010D8380E3Q39177110-760B7378-AD86-46B7-9517-19A01ADF356BQ42596233-A62420E9-B39F-4A34-B700-0F98EA7D19E8Q43687967-A7BC82BB-7C22-45AF-8853-EEF9C3D3EEB4Q43739203-34B19272-5951-47BD-8FE8-EB9BE3C2F894Q45849803-AF10B17A-E8F2-4FF6-AD13-2A60CB761568Q48251318-7D8D5DD8-E6E9-49C8-90E0-F69F814F3B61Q50296610-17244709-D6CB-4987-AB09-9FE8835BFA42
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Osteoporosis in Parkinson's disease.
@ast
Osteoporosis in Parkinson's disease.
@en
Osteoporosis in Parkinson's disease.
@nl
type
label
Osteoporosis in Parkinson's disease.
@ast
Osteoporosis in Parkinson's disease.
@en
Osteoporosis in Parkinson's disease.
@nl
prefLabel
Osteoporosis in Parkinson's disease.
@ast
Osteoporosis in Parkinson's disease.
@en
Osteoporosis in Parkinson's disease.
@nl
P1476
Osteoporosis in Parkinson's disease
@en
P2093
Carlo Cisari
Giovanni Sguazzini Viscontini
P304
P356
10.1016/J.PARKRELDIS.2009.02.009
P4011
f8a7888ceceec28668d83bb554331df52df74719
P577
2009-04-05T00:00:00Z